Published in Gastroenterol Res Pract on November 14, 2013
Intestinal Microbiota, Lipids, and the Pathogenesis of Intestinal Failure-Associated Liver Disease. J Pediatr (2015) 0.81
Parenteral Nutrition-Associated Cholestasis in Very Low Birth Weight Infants: A Single Center Experience. Pediatr Gastroenterol Hepatol Nutr (2016) 0.75
The Effect of Fish Oil-Based Lipid Emulsion and Soybean Oil-Based Lipid Emulsion on Cholestasis Associated with Long-Term Parenteral Nutrition in Premature Infants. Gastroenterol Res Pract (2016) 0.75
Total parenteral nutrition promotes bacterial translocation from the gut. Surgery (1988) 2.65
Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med (2000) 2.08
Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics (2008) 2.02
Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enteral Nutr (2001) 1.52
Increased incidence of parenteral nutrition-associated cholestasis with aminosyn PF compared to trophamine. J Perinatol (2003) 1.45
Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition. J Pediatr Gastroenterol Nutr (1998) 1.36
The effect of parenteral nutrition on gastrointestinal immunity. The importance of enteral stimulation. Ann Surg (1985) 1.34
Hepatic "intravenous fat pigment" in infants and children receiving lipid emulsion. J Pediatr Surg (1975) 1.30
Neonatal cholestasis. Pediatr Rev (2004) 1.25
The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition (1998) 1.21
Endotoxin effects on the liver. Life Sci (1977) 1.15
Liver complications of pediatric parenteral nutrition--epidemiology. Nutrition (1998) 1.14
Total parenteral nutrition induced liver pathology: an autopsy series of 24 newborn cases. Pediatr Dev Pathol (2004) 1.11
Intrahepatic cholestasis associated with parenteral nutrition in premature infants. Pediatrics (1979) 1.01
Cholestasis in immature newborn infants: is parenteral alimentation responsible? J Pediatr (1975) 1.00
Parenteral nutrition-associated liver disease and the role for isolated intestine and intestine/liver transplantation. Hepatology (2006) 0.99
Intravenous fish oil emulsion attenuates total parenteral nutrition-induced cholestasis in newborn piglets. Pediatr Res (1999) 0.98
Cholestasis induced by total parenteral nutrition. Clin Liver Dis (2008) 0.96
Omega-3 fatty acids improve hepatic steatosis in a murine model: potential implications for the marginal steatotic liver donor. Transplantation (2005) 0.96
The route of lipid administration affects parenteral nutrition-induced hepatic steatosis in a mouse model. J Pediatr Surg (2005) 0.93
Jaundice associated with bacterial infection in the newborn. Am J Dis Child (1971) 0.92
Pigment deposition in the reticuloendothelial system after fat emulsion infusion. Arch Dis Child (1976) 0.92
Demographic and nutritional factors associated with prolonged cholestatic jaundice in the premature infant. J Perinatol (2007) 0.90
Intrauterine growth restriction impacts tolerance to total parenteral nutrition in extremely low birth weight infants. J Perinatol (2004) 0.89
A contemporary analysis of parenteral nutrition-associated liver disease in surgical infants. J Pediatr Surg (2011) 0.88
Cholestasis associated with total parenteral nutrition. J Pediatr Gastroenterol Nutr (1986) 0.88
Sepsis-associated cholestasis. Gastroenterology (1997) 0.86
Pattern and prognosis of liver function test abnormalities during parenteral nutrition in inflammatory bowel disease. Hepatology (1985) 0.86
Localization and quantification of glucose transporters in liver of growth-retarded fetal and neonatal rats. Am J Physiol (1999) 0.86
TPN-associated hyperbilirubinemia: a common problem in newborn surgical patients. J Pediatr Surg (1985) 0.85
Prospective controlled study of parenteral nutrition-associated cholestatic jaundice: effect of protein intake. J Pediatr (1980) 0.85
Cholestasis caused by lipid emulsions. Surg Gynecol Obstet (1982) 0.84
Influence of intrauterine growth retardation on parameters of liver function in low birth weight infants. Eur J Pediatr (1990) 0.84
Defective biliary secretion during total parenteral nutrition: probable mechanisms and possible solutions. J Pediatr Gastroenterol Nutr (1995) 0.83
Nutritional factors contributing to the development of cholestasis during total parenteral nutrition. Adv Pediatr (2003) 0.83
Development of fat emulsions. JPEN J Parenter Enteral Nutr (1981) 0.82
Chronic cholestasis and macronutrient excess in patients treated with prolonged parenteral nutrition. Nutrition (1992) 0.81
Male sex predisposes the newborn surgical patient to parenteral nutrition-associated cholestasis and to sepsis. Arch Surg (2002) 0.81
Metabolic differences between AGA- and SGA-infants of very low birthweight. I. Relationship to intrauterine growth retardation. Acta Paediatr Scand (1988) 0.81
The effect of short-term total parenteral nutrition on hepatic function in the human neonate: a prospective randomized study demonstrating alteration of hepatic canalicular function. J Pediatr (1981) 0.80
Increasing dextrose concentrations in total parenteral nutrition (TPN) causes alterations in hepatic morphology and plasma levels of insulin and glucagon in rats. J Surg Res (1988) 0.79
THE THEORETICAL BACKGROUND OF THE INTRAVENOUS NUTRITION WITH FAT EMULSIONS. Nutr Dieta Eur Rev Nutr Diet (1963) 0.79
Follow-up studies of children treated with a long-term intravenous nutrition (IVN) during the neonatal period. J Pediatr Surg (1982) 0.79
Total parenteral nutrition impairs bile flow and alters bile composition in newborn piglet. Dig Dis Sci (1996) 0.78
TPN cholestasis in premature infants: the role of parenteral nutrition solutions. Pediatr Ann (1987) 0.77
Lipid intolerance in newborns is associated with hepatic dysfunction but not infection. Arch Pediatr Adolesc Med (1995) 0.77
Use of intravenous lipid and hyperbilirubinemia in the first week. J Pediatr Gastroenterol Nutr (1992) 0.77
Similar liver function abnormalities occur in patients receiving glucose-based and lipid-based parenteral nutrition. Am J Gastroenterol (1983) 0.76